Pharmacodynamic evaluation of YH4808 for Helicobacter pylori eradication in healthy subjects
Open Access
- 1 January 2020
- journal article
- research article
- Published by Korean Society for Clinical Pharmacology and Therapeutics in Translational and Clinical Pharmacology
- Vol. 28 (3) , 136-146
Abstract
Park H, et al. Transl Clin Pharmacol. 2020 Sep;28:e16. /Synapse/10.12793/tcp.2020.28.e16Keywords
Funding Information
- Yuhan corp
This publication has 18 references indexed in Scilit:
- Diagnosis and Treatment of Helicobacter Pylori Infection: Korean and Overseas GuidelinesThe Korean Journal of Medicine, 2015
- Optimum duration of regimens for Helicobacter pylori eradicationCochrane Database of Systematic Reviews, 2013
- Effect of the CYP2C19 polymorphism on the eradication rate of Helicobacter pylori infection by 7‐day triple therapy with regular proton pump inhibitor dosageJournal of Gastroenterology and Hepatology, 2008
- Meta-analysis: Duration of First-Line Proton-Pump Inhibitor–Based Triple Therapy for Helicobacter pylori EradicationAnnals of Internal Medicine, 2007
- Eradication Therapy for Helicobacter pyloriGastroenterology, 2007
- Evidence that the Degree and Duration of Acid Suppression are Related to Helicobacter pylori Eradication by Triple TherapyHelicobacter, 2007
- Current concepts in the management of Helicobacter pylori infection: the Maastricht III Consensus ReportGut, 2007
- Pathogenesis ofHelicobacter pyloriInfectionClinical Microbiology Reviews, 2006
- Helicobacter pylori and gastric diseasesBMJ, 1998
- Relationship between Helicobacter pylori eradication and reduced duodenal and gastric ulcer recurrence: A reviewGastroenterology, 1996